The CYP2C19 genotype may be relevant to guide individualized antiplatelet treatment regimens in patients with stenting procedure for cerebral artery stenosis in China, which will improve the efficacy of clopidogrel and reduce the incidence of postoperative adverse cerebrovascular events caused by low reactivity to clopidogrel. Here, CYP2C19 is linked to cerebral artery stenosis.